Abon Pharmaceuticals, LLC is a specialty pharma company and preferred partner in the development of difficult proprietary and generic products with high formulation barriers. Abon is capable of developing a broad range of dosage forms with the highest quality and speed.
| Website | http://www.abonpharma.com |
| Revenue | $6.7 million |
| Employees | 61 (40 on RocketReach) |
| Founded | 2009 |
| Phone | +1 201-767-1102 |
| Technologies |
HTML
,
Bootstrap
,
jQuery
+3 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Pharmaceutical Development, Drug Formulation, Specialty Pharmaceuticals, Drug Development Services, Generic Drugs, Proprietary Products, Cdmo, Dosage Forms, Pharmaceutical Solutions, Drug Products, Pharmaceutical Manufacturing, Pharmaceutical Ingredients, Quality Control, Pharma, Supply Chain, Regulatory Affairs |
| Competitors | Mylan Belgium, Teva Pharmaceuticals USA, Inc., Bristol Myers Squibb, Amgen, Novartis, Roche, AbbVie, Johnson & Johnson, Pfizer, GSK +44 more (view full list) |
Looking for a particular Abon Pharmaceuticals, LLC employee's phone or email?
The Abon Pharmaceuticals, LLC annual revenue was $6.7 million in 2026.
Salah Ahmed is the president and CEO of Abon Pharmaceuticals, LLC.
40 people are employed at Abon Pharmaceuticals, LLC.